Fortress Biotech Inc (NASDAQ: FBIO) is -24.44% lower on its value in year-to-date trading and has touched a low of $1.33 and a high of $2.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FBIO stock was last observed hovering at around $1.50 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $1.53, the stock is -2.21% and -5.68% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.13 million and changing 2.00% at the moment leaves the stock -15.33% off its SMA200. FBIO registered -13.07% loss for a year compared to 6-month gain of -11.05%. The firm has a 50-day simple moving average (SMA 50) of $1.6222 and a 200-day simple moving average (SMA200) of $1.80725.
The stock witnessed a -11.05% gain in the last 1 month and extending the period to 3 months gives it a -19.90%, and is 8.51% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.00% over the week and 8.28% over the month.
Fortress Biotech Inc (FBIO) has around 101 employees, a market worth around $45.19M and $57.67M in sales. Profit margin for the company is -96.68%. Distance from 52-week low is 15.47% and -47.06% from its 52-week high. The company has generated returns on investments over the last 12 months (-58.42%).
with sales reaching $11.62M over the same period.The EPS is expected to grow by 36.06% this year, but quarterly earnings will post 26.60% year-over-year. Quarterly sales are estimated to shrink -10.82% in year-over-year returns.
60.0 institutions hold shares in Fortress Biotech Inc (FBIO), with institutional investors hold 22.09% of the company’s shares. The shares outstanding are 27.91M, and float is at 21.10M with Short Float at 17.22%. Institutions hold 16.25% of the Float.
The top institutional shareholder in the company is ROSALIND ADVISORS, INC. with over 0.61 million shares valued at $1.04 million. The investor’s holdings represent 3.3182 of the FBIO Shares outstanding. As of 2024-06-30, the second largest holder is ACADIAN ASSET MANAGEMENT LLC with 0.28 million shares valued at $0.47 million to account for 1.515 of the shares outstanding. The other top investors are SHIKIAR ASSET MANAGEMENT INC which holds 0.23 million shares representing 1.2337 and valued at over $0.39 million, while GSA CAPITAL PARTNERS LLP holds 1.0661 of the shares totaling 0.2 million with a market value of $0.33 million.
Fortress Biotech Inc (FBIO) Insider Activity
The most recent transaction is an insider purchase by ROSENWALD LINDSAY A MD, the company’s PRESIDENT, CEO & CHAIRMAN. SEC filings show that ROSENWALD LINDSAY A MD bought 763,359 shares of the company’s common stock on Sep 23 ’24 at a price of $1.84 per share for a total of $1.4 million. Following the purchase, the insider now owns 3.66 million shares.
Fortress Biotech Inc disclosed in a document filed with the SEC on Jul 11 ’24 that ROSENWALD LINDSAY A MD (President, CEO & Chairman) bought a total of 5,000 shares of the company’s common stock. The trade occurred on Jul 11 ’24 and was made at $7.48 per share for $37418.0. Following the transaction, the insider now directly holds 0.13 million shares of the FBIO stock.
Still, SEC filings show that on Jul 10 ’24, Jin David (Chief Financial Officer) acquired 500 shares at an average price of $7.50 for $3750.0. The insider now directly holds 500 shares of Fortress Biotech Inc (FBIO).
